Perbedaan Kalbe Farma Tbk dan Prodia Diagnostic Line Tbk: Kalbe Farma Tbk diperdagangkan di Rp800 (kapitalisasi pasar 37,45 T, volume 24 jam 76,98 jt), sedangkan Prodia Diagnostic Line Tbk diperdagangkan di Rp270 (kapitalisasi pasar 474,07 M, volume 24 jam 21,23 jt). Perbedaan utamanya: Kalbe Farma Tbk jauh lebih besar — sekitar 79× kapitalisasi pasar Prodia Diagnostic Line Tbk, dan Kalbe Farma Tbk lebih aktif diperdagangkan (76,98 jt vs 21,23 jt). Mana yang lebih baik tergantung tujuan investasimu.
| KLBF | PRDL | |
|---|---|---|
Kapitalisasi Pasar | 37,45 T | 474,07 M |
Volume | 76,98 jt | 21,23 jt |
Lot | 769,75 rb | 212,3 rb |
Perputaran | 61,63 M | 5,77 M |
Harga Rata-rata | 800,7 | 271,63 |
Nilai Transaksi | 61,63 M | 5,77 M |
Harga Ekuilibrium Indikatif | 800 | 270 |
Volume Ekuilibrium Indikatif | 40,55 rb | 2,21 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Selengkapnya di halaman KLBF →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Selengkapnya di halaman PRDL →